Mr. Jones of North Carolina introduced the following bill; which was referred to the Committee on Energy and Commerce
Introduced in House (IH)
To amend the Federal Food, Drug, and Cosmetic Act to mandate early access by desperately ill patients to treatment use of new drugs under clinical investigation for a serious or immediately life-threatening disease condition for whom no comparable or satisfactory drug or other therapy is available.
Walter B. Jones Jr.
Committee on Energy and Commerce (Standing)
United States Code References
21 U.S.C. 355
732 North Capitol Street, NW, Washington, DC 20401-0001